Andere Sprachen Ironwood Pharmaceuticals, Inc.

Aktien

A0X789

US46333X1081

IRWD

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 31.05.2024			% 5 Tage	% 1. Jan.
6,3 ^USD	+3,96 %		+5,88 %	-44,93 %

22.05.	Ironwood Pharmaceuticals Insider verkaufte Aktien im Wert von $436.136, laut einer aktuellen SEC Einreichung	MT
21.05.	Ironwood Pharmaceuticals, Inc. präsentiert auf der Digestive Disease Week 2024 aktuelle Daten aus der klinischen Phase-III-Studie STARS (Pivotal Phase III)	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ironwood Pharmaceuticals Insider Sold Shares Worth $436,136, According to a Recent SEC Filing	22.05.
Ironwood Pharmaceuticals, Inc. Presents Late-Breaking Data During the 2024 Digestive Disease Week Meeting from Its Pivotal Phase III Clinical Trial, STARS	21.05.
Sector Update: Health Care Stocks Higher Late Afternoon	09.05.
Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading	09.05.
Sector Update: Health Care	09.05.
Ironwood Pharmaceuticals' Shares Fall After Q1 Swings to a Non-GAAP Loss, Revenue Declines; 2024 Revenue Guidance Cut	09.05.
Transcript : Ironwood Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024	09.05.
Ironwood Pharmaceuticals, Inc. Revised Earnings Guidance for Its Fiscal Year 2024	09.05.
Ironwood Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Ironwood Pharmaceuticals, Inc. Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)	28.03.
Wall Street Set to Open Higher Thursday as Inflation Data Meets Forecasts	29.02.
Investors Await Slate of Economic Data as US Futures Move Lower in Thursday's Premarket Session	29.02.
Top Premarket Decliners	29.02.
Transcript : Ironwood Pharmaceuticals, Inc. - Special Call	29.02.
Ironwood says bowel disease treatment meets main goal in late-stage trial	29.02.
IRONWOOD PHARMACEUTICALS, INC. : Piper Sandler toujours positif	16.02.
Ironwood Pharmaceuticals Insider Sold Shares Worth $2,699,979, According to a Recent SEC Filing	15.02.
Ironwood Pharmaceuticals Insider Sold Shares Worth $588,538, According to a Recent SEC Filing	15.02.
Ironwood Pharmaceuticals Insider Sold Shares Worth $722,071, According to a Recent SEC Filing	15.02.
Ironwood Pharmaceuticals Q4 Non-GAAP Net Income Drops, Revenue Rises	15.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ironwood Pharmaceuticals, Inc.

Aktien

A0X789

US46333X1081

IRWD

Andere Sprachen

Filter